Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
Mendhekar
Dattatreya Namdeorao
DN
Inamdar
Amir
A
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D012120:Respiration Disorders / Q000139:chemically induced* / Q000188:drug therapy* / Q000209:etiology; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D003024:Clozapine; D018967:Risperidone